1. Exosomal GPT2 derived from triple‐negative breast cancer cells promotes metastasis by activating BTRC
   Mingqing Cui et al, 2023, Thoracic Cancer CrossRef
2. Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance
   Samuele Tardito et al, 2024, International Journal of Molecular Sciences CrossRef
3. Metabolism-regulated ferroptosis in cancer progression and therapy
   Lvlan Ye et al, 2024, Cell Death & Disease CrossRef
4. The role of PIK3CA gene mutations in colorectal cancer and the selection of treatment strategies
   Haitao Wang et al, 2024, Frontiers in Pharmacology CrossRef
5. Roles of glutamic pyruvate transaminase 2 in reprogramming of airway epithelial lipidomic and metabolomic profiles after smoking
   Furong Yan et al, 2024, Clinical and Translational Medicine CrossRef
6. Prognosis and immunotherapeutic implications of molecular classification of cervical cancer based on immunophenoscore-related genes
   Aihua Guo et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
7. Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseases
   Yaoyao Lu et al, 2022, Frontiers in Genome Editing CrossRef
8. Design, Synthesis and Biological Evaluation of 6-(Imidazo[1,2-a]pyridin-6-yl)quinazoline Derivatives as Anticancer Agents via PI3Kα Inhibition
   Mei Li et al, 2023, International Journal of Molecular Sciences CrossRef
9. A prognostic risk model, tumor immune environment modulation, and drug prediction of ferroptosis and amino acid metabolism-related genes in hepatocellular carcinoma
   Lina Ji et al, 2023, Human Cell CrossRef
10. Association of SIGLEC9 Expression with Cytokine Expression, Tumor Grading, KRAS, NRAS, BRAF, PIK3CA, AKT Gene Mutations, and MSI Status in Colorectal Cancer
    Błażej Ochman et al, 2024, Current Issues in Molecular Biology CrossRef